Scientific Study Published In Oncotarget Links E-Cigarettes To Health Hazards

Medical journal Oncotarget recently published a study that was conducted by the University of Rochester Medical Center. The study looked at the effect of using electronic cigarettes and the results of the study implied that the usage of these devices can cause damage to the teeth and gums of its users. When looking at the study’s participants at the molecular and cellular level, the effect of oral health when using an e-cigarette is comparable to the damage done by smoking conventional cigarettes. Visit Oncotarget’s profile page at Facebook.

Many users of these devices believe they are safer than regular cigarettes, a notion that this study says is likely incorrect. Just like regular cigarettes, the usage of e-cigarettes can lead to gum disease, rotting teeth, and cancer among other health issues. The inflammatory proteins that are inhaled can also cause lung damage and disease. One of the suspected causes of these health issues seems to be the chemical flavorings that are used in e-cigarettes. E-cigarettes also contain nicotine which is well documented as causing gum disease and other health risks.

The study concluded that more research needs to be conducted on e-cigarettes including longer term studies. The authors of the study also concluded that e-cigarette manufacturers need to be more forthcoming about what chemicals are in these products and what the dangers are that they contain.

Oncotarget is a peer-reviewed research journal that is published on a weekly basis. They publish scientific studies from a variety of medical disciplines and have as their stated goal to make the latest research quickly and widely available. While Oncotarget was initially focused on Oncology, the journal’s success has led to it also covering a wide range of other medical disciplines.

Oncotarget was founded by two doctors at the Roswell Park Cancer Institute, Dr. Mikhail Blagosklonny and Dr. Andrei Gudkov. These two also serve as co-editors-in-chief of Oncotarget. The journal has been successfully publishing scientific papers for seven years and has proven to be a popular source of the latest information in the medical research community.

Read more: https://www.dovepress.com/oncotargets-and-therapy-journal